Psioxus Therapeutics converts GBP 1 million in loan notes from the Wellcome Trust

Mercia EIS Funds | 13th September, 2012
Psioxus Therapeutics converts GBP 1 million in loan notes from the Wellcome Trust
Mercia EIS Funds | 12th September, 2012
Mercia Fund Management congratulates PsiOxus Therapeutics on Best Biotech Fund Raiser award
Mercia EIS Funds | 10th September, 2012
Pro Bono Bio obtains exclusive licence from PolyTherics
Mercia EIS Funds | 6th September, 2012
Looking at university spin-outs: University of Birmingham
Mercia EIS Funds | 21st August, 2012
PolyTherics appoints new head of business development
Mercia EIS Funds | 20th July, 2012
Hybrid SEIS scheme investment fund launched – the Mercia Growth Fund
Mercia EIS Funds | 18th June, 2012
PolyTherics granted further patents for TheraPEG and GlycoPol
Mercia EIS Funds | 17th June, 2012
Allinea DDT the debugger of choice for the worlds most powerful supercomputer.
Mercia EIS Funds | 29th May, 2012
Pro Bono Bio and PolyTherics progress and expand their relationship for the development of improved blood factors
Mercia EIS Funds | 15th May, 2012
New Board Members join PolyTherics